Status:

TERMINATED

Multimodal Neuroimaging Analysis After Mild Traumatic Brain Injury

Lead Sponsor:

University Hospital, Bordeaux

Conditions:

Mild Traumatic Brain Injury

Eligibility:

MALE

18-30 years

Phase:

NA

Brief Summary

Mild Traumatic Brain Injury (mTBI), including concussion, is a real public health problem. Indeed mTBI might induce long-term brain disorders with increased risk of neurodegenerative diseases and the ...

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Applicable to all :
  • \- Male 18 to 25 years, enrolled in French Social Security.
  • Group of mTBI patients:
  • \- Diagnosis of mTBI in the last 2 weeks confirmed in emergency department of Bordeaux CHU, using the WHO definition (2004): "head trauma ≤ 24h with Glasgow Coma Scale score of 13-15 and with one or more of the three symptoms following: confusion or disorientation, loss of consciousness for 30 minutes or less, posttraumatic amnesia for less than 24h".
  • Group of footballers:
  • \- Member of the "CFA" and "U19" teams of "Girondins de Bordeaux".
  • Group of controls:
  • \- Practicing regular physical activity (excluding combat or contact sports).
  • Exclusion Criteria :
  • Abnormal neurological examination
  • Drug addiction including alcohol Taking drugs targeting the central nervous system History of head trauma, or other notion of central nervous system injury
  • History of severe high blood pressure, diabetes, chronic cardiovascular pathology, progressive or debilitating disease
  • Subject unable to give informed consent
  • Contraindication to MRI: head circumference\> 60 - Claustrophobia - Pacemaker, Implantable Neurostimulation, Implantable Defibrillator - Cochlear Implants - Ocular or cerebral ferromagnetic foreign body
  • Refusal to be informed of an abnormality detected during MRI.

Exclusion

    Key Trial Info

    Start Date :

    July 18 2016

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 29 2018

    Estimated Enrollment :

    41 Patients enrolled

    Trial Details

    Trial ID

    NCT03342612

    Start Date

    July 18 2016

    End Date

    January 29 2018

    Last Update

    February 26 2019

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    University Hospital Bordeaux

    Bordeaux, France, 33076